SCHEMBL19748411

SCHEMBL19748411

CS(=O)(=O)N(C(=N)S)S(C)(=O)=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8153868 0.75 KDM4E (0.31)
SCHEMBL21528306 0.67 KDM4E (0.40)
Sulfuric Acid SCHEMBL28112039 0.67 KDM4E (0.39)
SCHEMBL28449489 0.65 KDM4E (0.33)
SCHEMBL12914481 0.63
SCHEMBL29202325 0.63 KDM4E (0.31)
Thiourea SCHEMBL933625 0.63
SCHEMBL4982209 0.63 KDM4E (0.31)
SCHEMBL585350 0.61 CA1 (0.33)
Thiourea SCHEMBL28009945 0.61 KDM4E (0.46)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3475272-A1 PHTHALAZINE DERIVATIVES AS INHIBITORS OF PARP1, PARP2 AND/OR TUBULIN USEFUL FOR THE TREATMENT OF CANCER The Regents of The University of California (US) 2019-05-01 EP disclosed
WO-2017223516-A1 PHTHALAZINE DERIVATIVES AS INHIBITORS OF PARP1, PARP2 AND/OR TUBULIN USEFUL FOR THE TREATMENT OF CANCER THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2017-12-28 WO disclosed